Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 3,321

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

Dellinger, R. Phillip, Carlet, Jean M., Masur, Henry, Gerlach, Herwig, Calandra, Thierry, Cohen, Jonathan, Gea-Banacloche, Juan, Keh, Didier, Marshall, John C., Parker, Margaret M., Ramsay, Graham, Zimmerman, Janice L., Vincent, Jean-Louis, Levy, M. M.·2004·Intensive Care Medicine

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00134-004-2210-z

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 117

  1. Dellinger RP (2003) Cardiovascular management of septic shock. Crit Care Med 31:946–955 · DOI · Paper page
  2. Friedman G, Silva E, Vincent JL (1998) Has the mortality of septic shock changed with time? Crit Care Med 26:2078–2086 · DOI · Paper page
  3. Sackett DL (1989) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 95:2S–4S · DOI · Paper page
  4. Sprung CL, Bernard GR, Dellinger RP (2001) Introduction. Intensive Care Med 27 [Suppl] :S1-S2 · doi:10.1007/pl00020871
  5. Weinstein MP, Reller LP, Murphy JR, Lichtenstein KA (1983) The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 5:35–53 · DOI · Paper page
  6. Blot F, Schmidt E, Nitenberg G, Tancrède C, Laplanche A, Andremont A (1998) Earlier positivity of central venous versus peripheral blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 36:105–109 · DOI · Paper page
  7. Mermel LA, Maki DG (1993) Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med 119:270–272 · DOI · Paper page
  8. McCabe WR, Jackson GG (1962) Gram negative bacteremia. Arch Intern Med 110:92–100
  9. Kreger BE, Craven DE, McCabe WR (1980) Gram negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 68:344–355 · DOI · Paper page
  10. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:379–386 · DOI · Paper page
  11. Ibrahim EH, Sherman G, Ward S, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155 · DOI · Paper page
  12. Hatala R, Dinh T, Cook DJ (1996) Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 124:717–725 · DOI · Paper page
  13. Ali MZ, Goetz MB (1997) A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infec Dis 24:796–809 · DOI · Paper page
  14. Hyatt JM, McKinnon PS, Zimmer GS, Schentag JJ (1995) The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcomes. Focus on antibacterial agents. Clin Pharmacokinet 28:143–160 · DOI · Paper page
  15. Bufalari A, Giustozzi G, Moggi L (1996) Postoperative intraabdominal abscesses: percutaneous versus surgical treatment. Acta Chir Belg 96:197–200
  16. Centers for Disease Control and Prevention (2002) Guidelines for the prevention of intravascular catheter-related infections. MMWR Morb Mortal Wkly Rep 51:1–29
  17. O’Grady NP, Alexander M, Dellinger EPet al. (2002) Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 23:759–769 · DOI · Paper page
  18. Choi PT, Yip G, Quinonez LG, Quinonez LG, Cook DJ (1999) Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 27:200–210 · DOI · Paper page
  19. Cook D, Guyatt G (2001) Colloid use for fluid resuscitation: evidence and spin. Ann Intern Med 135:205–208 · DOI
  20. Schierhout G, Roberts I (1998) Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomized trials. BMJ 316:961–964 · DOI · Paper page
  21. Hollenberg SM, Ahrens TS, Astiz ME, (1999) Practice parameters for hemodynamic support of sepsis in adult patients. Crit Care Med 27:639–660 · DOI · Paper page
  22. LeDoux D, Astiz ME, Carpati CM, Rackow EC (2000) Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28:2729–2732 · DOI · Paper page
  23. Regnier B, Rapin M, Gory G, Lemaire F, Teisseire B, Harari A (1977) Haemodynamic effects of dopamine in septic shock. Intensive Care Med 3:47–53 · DOI
  24. Martin C, Papazian L, Perrin G, Saux P, Gouin F (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 103:1826–1831 · DOI · Paper page
  25. Martin C, Viviand X, Leone M, Thirion X (2000) Effect of norepinephrine on the outcome of septic shock. Crit Care Med 28:2758–2765 · DOI · Paper page
  26. De Backer D, Creteur J, Silva E, Vincent JL (2003) Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 31:1659–1667 · DOI · Paper page
  27. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139–2143 · DOI · Paper page
  28. Kellum J, Decker J (2003) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29:1526–1531 · DOI · Paper page
  29. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D (2003) Circulating vasopressin levels in septic shock. Crit Care Med 31:1752–1758 · DOI · Paper page
  30. Holmes CL, Patel BM, Russell JA, Russell JA, Walley KR (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120:989–1002 · DOI · Paper page
  31. Malay MB, Ashton RC, Landry DW, Townsend RN (1999) Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47:699–705 · DOI · Paper page
  32. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA (2001) The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27:1416–1421 · DOI · Paper page
  33. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 333:1025–1032 · DOI · Paper page
  34. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330:1717–1722 · DOI · Paper page
  35. Annane D, Sebille V, Charpentier C et al. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871 · DOI · Paper page
  36. Briegel J, Forst H, Haller M et al. (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27:723–732 · DOI · Paper page
  37. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26:645–650 · DOI · Paper page
  38. Annane D, Cavaillon JM (2003) Corticosteroids in sepsis: from bench to bedside? Shock 20:197–207 · DOI
  39. Marik PE, Zaloga GP (2003) Adrenal insufficiency during septic shock. Crit Care Med 31:141–145 · DOI · Paper page
  40. Cooper MS, Stewart PM (2003) Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348:727–734 · DOI · Paper page
  41. Bone RC, Fisher CJ, Clemmer TP (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653–658 · DOI · Paper page
  42. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, Fisher CJ Jr (1995) Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23:1430–1439 · DOI · Paper page
  43. The Veterans Administration Systemic Sepsis Cooperative Study Group (1987) Effect on high-dose glucocorticoid therapy on mortality in patients with clinical signs of sepsis. N Engl J Med 317:659–665 · DOI · Paper page
  44. Bernard GR, Vincent JL, Laterre PF et al. Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699–709 · DOI · Paper page
  45. Marik PE, Sibbald WJ (1993) Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 269:3024–3029 · DOI · Paper page
  46. Lorente JA, Landín L, De Pablo R, Renes E, Rodriguez-Diaz R, Liste D (1993) Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med 21:1312–1318 · DOI
  47. Corwin HL, Gettinger A, Rodriguez RM et al. (1999) Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized double-blind, placebo-controlled trial. Crit Care Med 27:2346–2350 · DOI · Paper page
  48. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T; EPO Critical Care Trials Group (2002) Efficacy of recombinant human erythropoietin in critically ill patients. JAMA 288:2827–2835 · DOI · Paper page
  49. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists (1994) Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. JAMA 271:777–781 · DOI · Paper page
  50. Practice Guidelines for Blood Component Therapy (1996) A report by the American Society of Anaesthesiologists Task Force on Blood Component Therapy. Anesthesiology 84:732–747 · DOI · Paper page
  51. Warren BL, Eid A, Singer P et al. (2001) High-dose antithrombin III in severe sepsis. A randomized controlled trial. JAMA 286:1869–1878 · DOI · Paper page
  52. Stewart TE, Meade MO, Cook DJ et al. (1998) Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group. N Engl J Med 338:355–361 · DOI · Paper page
  53. Brower RG, Shanholtz CB, Fessler HE et al. (1999) Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 27:1492–1498 · DOI · Paper page
  54. Brower RG, Fessler HE (2000) Mechanical ventilation in acute lung injury and acute respiratory distress syndrome. Clin Chest Med 21:491–510 · DOI
  55. Hickling KG, Walsh J, Henderson S, Jackson R (1994) Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 22:1568–1578 · DOI · Paper page
  56. Bidani A, Tzouanakis AE, Cardenas VJ, Zwischenberger JB (1994) Permissive hypercapnia in acute respiratory failure. JAMA 272:957–962 · DOI · Paper page
  57. Marini JJ, Ravenscraft SA (1992) Mean airway pressure: physiologic determinants and clinical importance–Part I: physiologic determinants and measurements. Crit Care Med 20:1461–1472 · DOI
  58. Gattinoni L, Marcolin R, Caspani ML, Fumagalli R, Mascheroni D, Pesenti A (1985) Constant mean airway pressure with different patterns of positive pressure breathing during the adult respiratory distress syndrome. Bull Eur Physiopathol Respir 21:275–279
  59. Pesenti A, Marcolin R, Prato P, Borelli M, Riboni A, Gattinoni L (1985) Mean airway pressure vs. positive end-expiratory pressure during mechanical ventilation. Crit Care Med 13:34–37 · DOI
  60. Jolliet P, Bulpa P, Chevrolet JC (1998) Effects of the prone position on gas exchange and hemodynamics in severe acute respiratory distress syndrome. Crit Care Med 26:1977–1985 · DOI · Paper page
  61. Chatte G, Sab JM, Dubois JM, Sirodot M, Gaussorgues P, Robert D (1997) Prone position in mechanically ventilated patients with severe acute respiratory failure. Am J Respir Crit Care Med 155:473–478 · DOI · Paper page
  62. Esteban A, Alia I, Tobin MJ et al. (1999) Effect of spontaneous breathing trial duration on outcome of attempts to discontinue mechanical ventilation. Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 159:512–518 · DOI · Paper page
  63. Ely EW, Baker AM, Dunagan DP et al. (1996) Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 335:1864–1869 · DOI · Paper page
  64. Esteban A, Alia I, Gordo F et al. (1997) Extubation outcome after spontaneous breathing trials with T-tube or pressure support ventilation. The Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 156:459–465 · DOI · Paper page
  65. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G (1998) The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest 114:541–548 · DOI · Paper page
  66. Kress JP, Pohlman AS, O’Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342:1471–1477 · DOI · Paper page
  67. Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W, Kollef MH (1999) Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 27:2609–2615 · DOI · Paper page
  68. Giostra E, Magistris MR, Pizzolato G, Cox J, Chevrolet JC (1994) Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Occurrence in a cluster group of seven patients and two sporadic cases, with electrophysiologic and histologic examination. Chest 106:210–220 · doi:10.1378/chest.106.1.210
  69. Rossiter A, Souney PF, McGowan S, Carvajal P (1991) Pancuronium-induced prolonged neuromuscular blockade. Crit Care Med 19:1583–1587 · DOI
  70. Partridge BL, Abrams JH, Bazemore C, Rubin R (1990) Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 18:1177–1179 · doi:10.1097/00003246-199010000-00025
  71. Vanderheyden BA, Reynolds HN, Gerold KB, Emanuele T (1992) Prolonged paralysis after long-term vecuronium infusion. Crit Care Med 20:304–307 · doi:10.1097/00003246-199202000-00019
  72. Meyer KC, Prielipp RC, Grossman JE, Coursin DB (1994) Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 78:772–774 · DOI
  73. Manthous CA, Chatila W (1994) Prolonged weakness after withdrawal of atracurium. Am J Resp Crit Care Med 150:1441–1443 · DOI
  74. Prielipp RC, Coursin DB, Scuderi PE et al. (1995) Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 81:3–12
  75. Brandom BW, Yellon FF, Lloyd ME et al. (1997) Recovery from doxacurium infusion administered to produce immobility for more than four days in pediatric patients in the intensive care unit. Anesth Analg 84:307–314 · doi:10.1213/00000539-199702000-00012
  76. Rudis MI, Sikora CA, Angus E, Peterson E, Popovich J Jr, Hyzy R, Zarowitz BJ (1997) A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med 25:575–583 · DOI
  77. Frankel H, Jeng J, Tilly E, St Andre A, Champion H (1996) The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit. Am Surg 62:503–506
  78. Berghe G van den, Wouters P, Weekers F et al. (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367 · DOI · Paper page
  79. Finney SJ, Zekveld C, Elia A, Evans TW (2003) Glucose control and mortality in critically ill patients. JAMA 290:2041–2047 · DOI · Paper page
  80. Berghe G Van den, Wouters PJ, Bouillon R et al. (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359–366 · DOI · Paper page
  81. Klein S, Kinney J, Jeejeebhoy K, Alpers D, Hellerstein M, Murray M, Twomey P (1997) Nutrition support in clinical practice: review of published data and recommendations for future research directions. A summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 66:683–706 · DOI · Paper page
  82. Mehta RL; McDonald B, Gabbai FB, Pahl M, Pascual MT, Farkas A, Kaplan RM; Collaborative Group for Treatment of ARF in the ICU (2001) A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60:1154–1163 · DOI · Paper page
  83. Kellum J, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N, Linde-Zwirble WT (2002) Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 28:29–37 · DOI · Paper page
  84. Cade JF (1982) High risk of the critically ill for venous thromboembolism. Crit Care Med 10:448–450 · DOI · Paper page
  85. Belch JJ, Lowe GD, Ward AG, Forbes CD, Prentice CR (1981) Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 26:115–117 · DOI · Paper page
  86. Samama MM, Cohen AT, Darmon JY et al. (1999) A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 341:793–800 · DOI · Paper page
  87. Borrero E, Bank S, Margolis I, Schulman ND, Chardavoyne R (1985) Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in patients who are critically ill. Am J Med 79:62–64 · DOI
  88. Bresalier RS, Grendell JH, Cello JP, Meyer AA (1987) Sucralfate versus titrated antacid for the prevention of acute stress-related gastrointestinal hemorrhage in critically ill patients. Am J Med 83:110–116 · DOI
  89. Cook D, Guyatt G, Marshall J et al. (1998) A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 338:791–797 · DOI · Paper page
  90. Stothert JC, Simonowitz DA, Dellinger EP et al. (1980) Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill. Ann Surg 192:169–174 · DOI
  91. Pollard AJ, Britto J, Nadel S, DeMunter C, Habibi P, Levin M (1999) Emergency management of meningococcal disease. Arch Dis Child 80:290–296 · DOI · Paper page
  92. Kanter RK, Zimmerman JJ, Strauss RH, Stoeckel KA (1986) Pediatric emergency intravenous access. Evaluation of a protocol. Am J Dis Child 140:132–134 · DOI
  93. Ngo NT, Cao XT, Kneen R et al. (2001) Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 32:204–213 · DOI · Paper page
  94. Carcillo JA, Davis AL, Zaritsky A (1991) Role of early fluid resuscitation in pediatric septic shock. JAMA 266:1242–1245 · doi:10.1001/jama.266.9.1242
  95. Powell KR, Sugarman LI, Eskenazi AE, Woodin KA, Kays MA, McCormick KL, Miller ME, Sladek CD (1990) Normalization of plasma arginine vasopressin concentrations when children with meningitis are given maintenance plus replacement fluid therapy. J Pediatr 117:515–522 · DOI
  96. Ceneviva G, Paschall JA, Maffei F, Carcillo JA (1998) Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 102:e19 · DOI · Paper page
  97. Keeley SR, Bohn DJ (1988) The use of inotropic and afterload-reducing agents in neonates. Clin Perinatol 15:467–489 · DOI
  98. Roberts JD Jr, Fineman JR, Morin FC 3rd et al. (1997) Inhaled nitric oxide and persistent pulmonary hypertension of the new born. Inhaled Nitric Oxide Study Group. N Engl J Med 336:605–610 · DOI · Paper page
  99. Barton P, Garcia J, Kouatli A, Kitchen L, Zorka A, Lindsay C, Lawless S, Giroir B (1996) Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 109:1302–1312 · DOI
  100. Lindsay CA, Barton P, Lawless S, Kitchen L, Zorka A, Garcia J, Kouatli A, Giroir B (1998) Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. J Pediatr 132:329–334 · DOI
  101. Irazuzta JE, Pretzlaff RK, Rowin ME (2001) Amrinone in pediatric refractory septic shock: an open-label pharmacodynamic study. Pediatr Crit Care Med 2:24–28 · DOI
  102. Lauterbach R, Pawlik D, Kowalczyk D, Ksycinski W, Helwich E, Zembala M (1999) Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. Crit Care Med 27:807–814 · DOI · Paper page
  103. Carcillo JA, Fields AI, American College of Critical Care Medicine Task Force Committee Members (2002) Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 30:1365–1378 · DOI · Paper page
  104. De Kleijn ED, Joosten KF, Van Rijn B, Westerterp M, De Groot R, Hokken-Koelega AC, Hazelzet JA (2002) Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease. Pediatr Infect Dis J 21:330–336 · DOI
  105. Riordan FA, Thomson AP, Ratcliffe JM, Sills JA, Diver MJ, Hart CA (1999) Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: evidence of adrenal insufficiency? Crit Care Med 27:2257–2261 · DOI
  106. Min M, U T, Aye M, Shwe TN, Swe T (1975) Hydrocortisone in the management of dengue shock syndrome. Southeast Asian J Trop Med Public Health 6:573–579
  107. Sumarmo, Talogo W, Asrin A, Isnuhandojo B, Sahudi A (1982) Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics 69:45–49 · doi:10.1542/peds.69.1.45
  108. Hazelzet JA, Kleijn ED de, Groot R de (2001) Endothelial protein C activation in meningococcal sepsis. N Engl J Med 345:1776–1777 · DOI
  109. Kleijn ED de, Groot R de, Hack CE, Mulder PG, Engl W, Moritz B, Joosten KF, Hazelzet JA (2003) Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 31:1839–1847 · DOI · Paper page
  110. Bilgin K, Yaramis A, Haspolat K, Tas MA, Gunbey S, Derman O (2001) A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics 107:36–41 · doi:10.1542/peds.107.1.36
  111. La Gamma EF, De Castro MH (2002) What is the rationale for the use of granulocyte and granulocyte-macrophage colony-stimulating factors in the neonatal intensive care unit? Acta Paediatr Suppl 91:109–116 · doi:10.1080/080352502320764283
  112. Chaïbou M, Tucci M, Dugas MA, Farrell CA, Proulx F, Lacroix J (1998) Clinically significant upper gastrointestinal bleeding acquired in a pediatric intensive care unit: a prospective study. Pediatrics 102:933–938 · DOI
  113. Gauvin F, Dugas M, Chaïbou M, Morneau S, Lebel D, Lacroix J (2001) The impact of clinically significant upper gastrointestinal bleeding in a pediatric intensive care unit. Pediatr Crit Care Med 2:294–298 · DOI
  114. Alejandria MM, Lansang MA, Dans LF, Mantaring JB (2002) Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev (1):CD001090
  115. Meyer DM, Jessen ME (1997) Results of extracorporeal membrane oxygenation in children with sepsis. The Extracorporeal Life Support Organization. Ann Thorac Surg 63:756–761 · DOI
  116. Goldman AP, Kerr SJ, Butt W, Marsh MJ, Murdoch IA, Paul T, Firmin RK, Tasker RC, Macrae DJ (1997) Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet 349:466–469 · DOI
  117. Brochard L, Rauss A, Benito S, Conti G, Mancebo J, Rekik N, Gasparetto A, Lemaire F (1994) Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am J Respir Crit Care Med 150:896–903 · DOI · Paper page

Cited by

See all 3,321

Metadata

Authors
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., Ramsay, G., Zimmerman, J. L., Vincent, J.-L., & Levy, M. M.
Venue
Intensive Care Medicine
Published
2004-03-03
Volume
30
Issue
4
Pages
536-555
ISSN
  • 0342-4642 (ISSN-L)
  • 1432-1238
OpenAlex
W2163814324
Cited by
3,321
References
16
FWCI
225.32
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. https://app.cochat.ai/papers/10.1007/s00134-004-2210-z
The paper
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., Ramsay, G., Zimmerman, J. L., Vincent, J.-L., & Levy, M. M. (2004). Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Medicine. https://doi.org/10.1007/s00134-004-2210-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.